Oxaliplatin Induced Pulmonary Fibrosis: a Case Report
Oxaliplatin is part of the standard chemotherapy regimens for treating colorectal carcinoma. Pulmonary fibrosis is a serious but rare side effect of oxaliplatin treatment, which resulted in patient death in more than half of the reported cases. The precise pathophysiological mechanism of this phe...
Main Authors: | Mirjana Pavlović, Robert Šeparović, Tajana Silovski, Ana Tečić Vuger, Andreja Jurić |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2020-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/370926 |
Similar Items
-
Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report
by: Robert Šeparović, et al.
Published: (2018-01-01) -
Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01) -
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01) -
Does pulmonary fibrosis increase lung cancer risk?
by: Ahmed Ali, et al.
Published: (2022-01-01) -
Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)